Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Seminars in Oncology
Volume 33, Supplement 5, Pages 1-52 (April 2006)
Search Within This Issue
The Role of Alemtuzumab (Campath) in the Treatment of Hematologic Malignancies
Edited by Bruce D. Cheson MD

display abstract citation download email a colleague
Display:

free full text =free full text


Masthead free full text
page CO2
Full-Text PDF (39 KB)


Introduction free full text
Bruce D. Cheson
page 1
Full Text | Full-Text PDF (44 KB)


Monoclonal Antibody Therapy for B-Cell Malignancies
Bruce D. Cheson
pages 2-14
Abstract | Full Text | Full-Text PDF (201 KB)


Novel Therapeutic Strategies With Alemtuzumab for Chronic Lymphocytic Leukemia
Kanti R. Rai
pages 15-22
Abstract | Full Text | Full-Text PDF (180 KB)


Beyond Detectable Minimal Residual Disease in Chronic Lymphocytic Leukemia
Peter Hillmen
pages 23-28
Abstract | Full Text | Full-Text PDF (235 KB)


Strategies in the Management of Alemtuzumab-Related Side Effects
Anders Österborg, Claes Karlsson, Jeanette Lundin, Eva Kimby, Håkan Mellstedt
pages 29-35
Abstract | Full Text | Full-Text PDF (429 KB)


The Role of Alemtuzumab in Nonmyeloablative Hematopoietic Transplantation
Sergio Giralt
pages 36-43
Abstract | Full Text | Full-Text PDF (257 KB)


The Role of Alemtuzumab in the Management of T-Cell Malignancies
Claire Dearden
pages 44-52
Abstract | Full Text | Full-Text PDF (194 KB)

Frontmatter


Contents free full text
page A1
Full-Text PDF (32 KB)

display abstract citation download email a colleague
Display:
Advertisement